TGFB1 and Hepatic fibrosis: Furthermore, pirfenidone, a drug used in the treatment of IPF, which may also provide clinical benefits in renal and liver fibrosis [62,63,64], is believed to attain some of its benefits through modulation of both the Hh and TGF-β signaling pathways [65].